News & Updates
Filter by Specialty:
Donanemab puts brakes on Alzheimer’s disease progression
In the treatment of individuals with early symptomatic Alzheimer's disease and amyloid and tau pathology, the immunoglobulin G1 monoclonal antibody donanemab helps slow clinical progression, according to the results of the phase III TRAILBLAZER-ALZ 2 study.
Donanemab puts brakes on Alzheimer’s disease progression
26 Jul 2023Study: Older COVID-19 patients with epilepsy, multimorbidity highly vulnerable
Factors such as older age (>65 years), ventilator use, and higher comorbidity all contribute to increased mortality risk with COVID-19 among patients with epilepsy, as reported in a study.
Study: Older COVID-19 patients with epilepsy, multimorbidity highly vulnerable
24 Jul 2023Rotavirus infection linked to gastroenteritis, neurological complications in children
Children with rotavirus infection are at risk of developing gastroenteritis with severe but self-limiting neurological manifestations, reveals a study.
Rotavirus infection linked to gastroenteritis, neurological complications in children
20 Jul 2023Theophylline shows promise in SCI-induced bradycardia
Use of theophylline as an adjunctive therapy appears to lead to favourable outcomes among patients with bradycardia due to acute spinal cord injury (SCI) with an acceptable response to this agent, suggest the results of a study.